Carna Biosciences (TSE:4572) Net Margin %: 0.00% (As of Dec. 2025)


TSE:4572 Carna Biosciences Inc TSE:4572
25 GF Score
Price 円314.00
GF Value 円175.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Net Margin %?

Carna Biosciences TSE:4572 -3.68% 25 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 25/100 and a GF Value™ of 円175.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 946 Biotechnology companies, Carna Biosciences ranks worse than 67.55% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Carna Biosciences's Net Income for the three months ended in Dec. 2025 was 円0.0 Mil. Carna Biosciences's Revenue for the three months ended in Dec. 2025 was 円0.0 Mil. Therefore, Carna Biosciences's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Carna Biosciences's Net Margin % or its related term are showing as below:

TSE:4572' s Net Margin % Range Over the Past 10 Years
Min: -375   Med: -97.68   Max: 25.82
Current: -367.29

TSE:4572's Net Margin % is ranked worse than
67.55% of 946 companies
in the Biotechnology industry
Industry Median: -88.815 vs TSE:4572: -367.29

Carna Biosciences  (TSE:4572) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Carna Biosciences Net Margin % Related Terms

Carna Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Net Margin % Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.49 -97.32 -70.91 -342.42 -375.00

Carna Biosciences Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -348.15 -516.93 0.00 -279.49

TSE:4572 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Carna Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carna Biosciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Net Margin % falls into.


TSE:4572
25GF Score
Carna Biosciences Inc TSE:4572
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Carna Biosciences's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2171.47/579.057
=-375.00 %

Carna Biosciences's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Carna Biosciences (TSE:4572) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Carna Biosciences and its competitors. According to the industry distribution chart, Carna Biosciences ranks #639 out of 946 companies in the Biotechnology industry, placing it in the top 67.5%.
Is Carna Biosciences' Net Margin % too high?
Carna Biosciences' current Net Margin % is 0.00%. Based on the distribution chart, Carna Biosciences ranks #639 out of 946 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Carna Biosciences has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Carna Biosciences ranks #639 out of 946 companies for Net Margin %. This places Carna Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円175.60, compared to a current price of 円314.00 — trading 78.8% above its estimated fair value. The current Net Margin % is 0.00%. Carna Biosciences' overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円314.00 is trading 78.8% above its estimated GF Value™ of 円175.60. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Net Margin %: 0.00%
  • GF Value™: 円175.60 vs. price of 円314.00 (78.8% above fair value)
  • GF Score™: 25/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
25GF Score

Get the complete analysis for TSE:4572

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円314.00
Price
円175.60
GF Value